Biotech Stock News (NLNK) (TTPH)

NewLink Genetics (NASDAQ:NLNK) On Monday May 9, 2016 in after-hours trade share of NewLink Genetics tanked by 35% after the company had announced the failure of its phase 3 trial in treating patients with pancreatic cancer. Th phase 3 trial was known as the IMPRESS trial. This phase 3 trial had recruited a total of … Read more

Biotech Stock News (INO) (TTPH) (AKBA)

Inovio Pharmaceuticals (NASDAQ:INO)  On September 8, 2015 Inovio announced that it had dosed its first patient with its Universal HIV vaccine known as PennVax-GP. This trial is being run as a phase 1 trial that will assess the safety and tolerability of the vaccine in these patients with HIV. Although the phase 1 trial primarily … Read more